Related references
Note: Only part of the references are listed.In Vitro Activity of Telavancin in Combination with Colistin versus Gram-Negative Bacterial Pathogens
Michael Hornsey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Synthesis and Characterization of Photoswitchable Fluorescent SiO2 Nanoparticles
Florian May et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics
Jumana M. Yousef et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates
Kyong Ran Peck et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery
Rong Tong et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Light-induced cytotoxicity of a photochromic spiropyran
Jesper R. Nilsson et al.
CHEMICAL COMMUNICATIONS (2011)
Long-Lived Photoacid Based upon a Photochromic Reaction
Zheng Shi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Impact of pH on bacterial growth and activity of recent fluoroquinolones in pooled urine
Zeynep Erdogan-Yildirim et al.
RESEARCH IN MICROBIOLOGY (2011)
Determination of Spiropyran Cytotoxicity by High Content Screening and Analysis for Safe Application in Bionanosensing
Dania Movia et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
Chien-Yu Cheng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lauren M. Lim et al.
PHARMACOTHERAPY (2010)
In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008
A. Walkty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
Nobumasa Aoki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Photoacid for Extremely Long-Lived and Reversible pH-Jumps
Rui M. D. Nunes et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Subacute toxicity of colistin methanesulfonate in rats: Comparison of various intravenous dosage regimens
Stephanie J. Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance:: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative, bacteria
Vicente Pintado et al.
JOURNAL OF INFECTION (2008)
Synthesis and characterization of photoswitchable fluorescent silica nanoparticles
Jonas Foelling et al.
SMALL (2008)
Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections
M. E. Falagas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Bacterial killing in gastric juice -: effect of pH and pepsin on Escherichia coli and Helicobacter pylori
H. Zhu et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Toxicity, bioavailability and pharmacokinetics of a newly formulated colistin sulfate solution
B Lin et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2005)
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
ME Falagas et al.
BMC INFECTIOUS DISEASES (2005)
Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance
HG Prentice et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
